Original document(11 pages)  中文版
    The invention relates to a clazamycin enteric soluble compound and relative production. Wherein, said compound uses one or several units, while each unit comprises (a) core formed by clazamycin and one or several drug shaping agents; (b) at least one enteric soluble polymer film packing the core.
Application Number
申请号		 200610103994 Application Date
申请日		 2006.08.07
Title 名称 Clarithromycin enteric medicinal composition
Publication Number
公开号		 1923183 Publication Date
公开日		 2007.03.07
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K9/30;A61K9/48;A61K31/7048;A61P31/04
Applicant(s) Name
申请人		 Guangzhou Bei's Medicine Co., Ltd.
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 wangwei
More information 更  多  信  息


 Related patents information
Antibacterial composite medicine
Compound glucose injection with clindamycin and metronidazole
Clarithromycin injection
Cold resisting compound medicinal composition
Slowly released clamycin capsule
Constant speed released terbutaline controlled releasing preparation
Sow-released roxithromycin capsule and method for preparing same
Compound preparation of levocarnitine and coenzyme Q10
Compound preparation of levocarnitine and calcium pantothenate
Irbesartan gastric retention sustained-release pharmaceutical composition
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.